ESSA Pharma Statistics
Total Valuation
ESSA Pharma has a market cap or net worth of $9.23 million. The enterprise value is -$100.10 million.
| Market Cap | 9.23M |
| Enterprise Value | -100.10M |
Important Dates
The last earnings date was Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ESSA Pharma has 47.31 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 47.31M |
| Shares Outstanding | 47.31M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | 35.55% |
| Float | 33.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.08 |
| P/TBV Ratio | 0.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 69.07
| Current Ratio | 69.07 |
| Quick Ratio | 68.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.25% and return on invested capital (ROIC) is -15.57%.
| Return on Equity (ROE) | -21.25% |
| Return on Assets (ROA) | -15.25% |
| Return on Invested Capital (ROIC) | -15.57% |
| Return on Capital Employed (ROCE) | -27.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$721,863 |
| Employee Count | 35 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.63% in the last 52 weeks. The beta is 1.53, so ESSA Pharma's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | -96.63% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 15.74 |
| Average Volume (20 Days) | 2,884,863 |
Short Selling Information
| Short Interest | 1.35M |
| Short Previous Month | 3.66M |
| Short % of Shares Out | 4.03% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.66M |
| Pretax Income | -25.27M |
| Net Income | -25.27M |
| EBITDA | n/a |
| EBIT | -29.66M |
| Earnings Per Share (EPS) | -$0.57 |
Balance Sheet
The company has $109.62 million in cash and n/a in debt, giving a net cash position of $109.62 million or $2.32 per share.
| Cash & Cash Equivalents | 109.62M |
| Total Debt | n/a |
| Net Cash | 109.62M |
| Net Cash Per Share | $2.32 |
| Equity (Book Value) | 108.90M |
| Book Value Per Share | 2.45 |
| Working Capital | 108.90M |
Cash Flow
| Operating Cash Flow | -20.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -20.88M |
| FCF Per Share | -$0.44 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ESSA Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -265.43% |
| FCF Yield | -219.42% |
Analyst Forecast
The average price target for ESSA Pharma is $2.00, which is 925.12% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | 925.12% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 25, 2018. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 25, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |